SYBX Gross Margin

The Gross Margin of Synlogic Inc (SYBX) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SYBX Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

SYBX Gross Margin - Peers Comparison

Ticker	Name	Value
BCLI	Brainstorm Cell Therapeutics Inc	7775.20%
FENC	Fennec Pharmaceuticals Inc	93.30%
GLTO	Galecto Inc	7775.20%
SCPS	Scopus Biopharma Inc	7775.20%
ATNF	180 Life Sciences Corp	7775.20%
AMGN	Amgen Inc	61.53%
ENOB	Enochian Biosciences Inc	100.00%
PSTI	Pluristem Therapeutics Inc	100.00%
PTN	Palatin Technologies Inc	97.83%
AEZS.TO	Aeterna Zentaris Inc	95.06%
CELC	Celcuity Inc	7775.20%
INMB	INmune Bio Inc	7775.20%
MRNA	Moderna Inc	70.06%
ABBV	Abbvie Inc	69.99%
ENLV	Enlivex Therapeutics Ltd	7775.20%
ONC.TO	Oncolytics Biotech Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
XFOR	X4 Pharmaceuticals Inc	68.83%
AYLA	Old Ayala Inc	-
950220.KQ	Neoimmunetech Inc	7775.20%
LGVN	Longeveron Inc	78.76%
LPTX	Leap Therapeutics Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
WLLW.TO	Willow Biosciences Inc	-809.99%
950160.KQ	Kolon TissueGene Inc	11.72%
DYAI	Dyadic International Inc	65.82%
EVAX	Evaxion Biotech A/S	7775.20%
NYMX	Nymox Pharmaceutical Corp	-
ORGS	Orgenesis Inc	-1080.19%
AXLA	Axcella Health Inc	7775.20%
ARAV	Aravive Inc	7775.20%
ALRN	Aileron Therapeutics Inc	7775.20%
ATOS	Atossa Therapeutics Inc	100.00%
GILD	Gilead Sciences Inc	78.26%
PHGE	Biomx Inc	7775.20%
950200.KQ	Psomagen Inc	23.13%